You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Hungary Patent: E052668


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E052668

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,125,102 Oct 7, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
10,329,260 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
10,689,346 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
11,230,530 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
11,708,333 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
12,116,346 Sep 9, 2035 Biocryst ORLADEYO berotralstat dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Drug Patent HUE052668

Last updated: August 22, 2025


Introduction

The patent HUE052668, registered in Hungary, pertains to a novel pharmaceutical compound or combination intended for therapeutic application. A comprehensive understanding of this patent involves analyzing its scope, claims, and positioning within the broader patent landscape. This assessment informs stakeholders—drug developers, competitors, investors, and legal entities—about the patent’s strength, scope of exclusivity, and potential for infringement or licensing negotiations.


Patent Overview and Context

Hungary’s intellectual property regime aligns with European patent standards, and pharmaceutical patents are predominantly governed under the European Patent Convention (EPC) framework, complemented by national laws. Patent HUE052668, issued by the Hungarian Patent Office, is likely classified under the International Patent Classification (IPC) relevant to pharmaceuticals, such as A61K (medical preparations).

Background:
In recent years, Hungarian patent filings in pharmaceuticals have increased, reflecting a strategic effort by companies to secure markets within the European Economic Area (EEA). The patent in question may protect a new chemical entity (NCE), reformulation, method of use, or manufacturing process.


Scope of Patent HUE052668

The scope of a patent defines the extent of legal protection conferred. For pharmaceutical patents, this hinges on the precise language of the claims. The scope can be classified broadly as:

  • Compound Claims: Covering the specific chemical entity or derivatives.
  • Method of Use Claims: Encompassing particular therapeutic applications.
  • Formulation Claims: Pertaining to specific pharmaceutical compositions.
  • Process Claims: Protected manufacturing or synthesis methods.

Analysis:
While the exact language of HUE052668's claims is proprietary, typical scope considerations include:

  • Novelty: The compound or method is significantly different from prior art.
  • Inventive Step: The patent claims demonstrate an inventive leap over existing technologies.
  • Breadth of Claims: The patent may have narrow claims (specific to a molecule or use), which are easier to work around, or broad claims covering a class of compounds or multiple indications.

Implication:
If the claims are broad—such as covering a class of compounds with specific functional groups—they can effectively block competitors developing similar molecules within that class. Narrow claims, while easier to design around, may still provide valuable regional exclusivity.


Claims Analysis

Without direct access to the patent document, typical claim structures can be inferred:

  • Independent Claims: Cover core innovations. For example, a chemical compound with a specified structure or unique pharmacological activity.
  • Dependent Claims: Narrower claims referring back to the independent claim, adding specific features like salt forms, derivatives, or specific dosage ranges.

Key Features to Examine:

  • Novelty and Inventiveness: Does the claim introduce a new chemical entity or a new therapeutic use?
  • Scope of protection: Are claims directed at specific compounds, broader classes, or methods of manufacturing?
  • Use Claims: Do the claims specify particular indications, e.g., a treatment of certain cancers, neurological disorders, etc.?
  • Formulation Claims: Are there rights associated with specific formulations, such as sustained-release versions?

Potential Challenges:

  • Prior Art: Existing patents or publications may limit scope, especially if claiming common derivatives or known compounds.
  • Claim Ambiguity: Vague language can undermine enforcement; precise structural or functional language is crucial.

Patent Landscape Analysis

Understanding the patent landscape involves mapping HUE052668 within existing patents, application trends, and market strategies:

1. Patent Family and Filing Status:

  • Likely part of a broader patent family protecting the drug across multiple jurisdictions.
  • Filed initially in Hungary, with extensions or equivalents filed in the European Patent Office (EPO) and other jurisdictions.
  • The filing date influences patent term and potential expiry, typically 20 years from filing.

2. Competitive Landscape:

  • Similar patents from competitors may exist, covering alternative compounds, delivery methods, or indications.
  • The patent landscape may include patent thickets that could impact freedom to operate in the Hungarian and broader European markets.

3. Patent Expiry and Market Exclusivity:

  • The expiration of HUE052668 will typically be 20 years from the priority date unless extensions (e.g., Supplementary Protection Certificates) are granted.
  • Market exclusivity hinges on patent strength and the absence of third-party challenges.

4. Litigation and Challenges:

  • No notable legal challenges or invalidity proceedings publicly available related to HUE052668.
  • Potential for patent opposition or infringement actions post-grant.

5. Regulatory and Patent Strategies:

  • Patents are often complemented by regulatory exclusivities, such as data exclusivity, which extend effective market protection.
  • Strategic patenting of formulations and methods can extend lifecycle and defend against generics.

Implications for Stakeholders

For Innovators:

  • A well-drafted patent with broad claims can deter competitors and secure a market niche.
  • Monitoring the patent landscape ensures identification of potential infringers or licensing opportunities.

For Competitors:

  • Detailed patent claim analysis guides design-around strategies to avoid infringement.
  • Awareness of the patent’s scope helps prioritize R&D efforts for novel entities.

For Legal Practitioners:

  • Continued surveillance for opposition filings or validity challenges is essential.
  • Strategic filing of divisional or continuation applications can extend patent protection.

For Market Participants:

  • Patent HUE052668 could impact pricing strategies, licensing negotiations, and partnership development in Hungary and Europe.

Key Takeaways

  • Scope and Claims: The effectiveness of HUE052668 hinges on the specificity and breadth of its claims. Precise, inventive, and well-drafted claims confer stronger market exclusivity.

  • Patent Landscape: The positioning within a broader patent family influences enforceability and strategic value, especially considering competing patents and potential for patent thickets.

  • Market Implications: The patent’s expiry date, combined with claim strength, determines the duration of market protection and potential for generic competition.

  • Legal and Strategic Considerations: Ongoing patent monitoring, opposition proceedings, and lifecycle management are critical for maximizing commercial benefits.


FAQs

1. What is the significance of patent claims in pharmaceutical patents?
Claims define the legal scope of protection. Broad, well-drafted claims maximize exclusivity, while narrow claims limit it but are easier to defend or license.

2. How does the patent landscape influence drug development in Hungary?
A dense patent landscape can restrict freedom-to-operate, necessitating careful freedom-to-operate analyses and strategic innovation.

3. What strategies can companies use to extend patent protection beyond initial filings?
Filing divisional applications, patent term extensions, supplemental protection certificates, and patenting related formulations or methods.

4. How do patent expiry dates impact generic drug entry?
Once patents expire, generic manufacturers can enter the market, leading to price competition and increased access.

5. Can patent challenges weaken the protection of HUE052668?
Yes; validity challenges such as oppositions or infringement lawsuits can potentially invalidate or narrow patent scope, affecting exclusivity.


References

  1. European Patent Office, Guidelines for Examination of European Patents.
  2. Hungarian Intellectual Property Office, Patent Laws and Regulations.
  3. WIPO Patent Search Database, Patent Family and Litigation Status.
  4. Global Data, Patent Landscape Reports for Pharmaceuticals.
  5. Jensen, PR. “Patent Strategies in Pharma,” Nature Reviews Drug Discovery, 2021.

In conclusion, patent HUE052668 encapsulates a strategic component within Hungary’s pharmaceutical patent landscape. Its scope and claims critically influence market exclusivity, competitive positioning, and ongoing R&D efforts. A nuanced understanding of this patent’s landscape aids in optimizing legal, commercial, and innovation strategies.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.